BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721
1698 results:

  • 1. OSW-1 triggers necroptosis in colorectal cancer cells through the RIPK1/RIPK3/MLKL signaling pathway facilitated by the RIPK1-p62/SQSTM1 complex.
    Wang N; Li CY; Yao TF; Kang XD; Guo HS
    World J Gastroenterol; 2024 Apr; 30(15):2155-2174. PubMed ID: 38681991
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1.
    Zhang J; Wang Y; Hou S; Chi X; Ding D; Xue M; Zhang M; Wang J; Shuai J; Sun H; Gao Q; Kang C
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666541
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CircCOL1A1 promotes proliferation, migration, and invasion of colorectal cancer (CRC) cells and glutamine metabolism through GLS1 up-regulation by sponging miR-214-3p.
    Liu J; Zhang X; Yang M; Zhang X
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):211. PubMed ID: 38662258
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment.
    Ottaiano A; Santorsola M; Ianniello M; Ceccarelli A; Casillo M; Sabbatino F; Petrillo N; Cascella M; Caraglia F; Picone C; Perri F; Sirica R; Zappavigna S; Nasti G; Savarese G; Caraglia M
    J Transl Med; 2024 Apr; 22(1):379. PubMed ID: 38650006
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Promising anticancer activity of cromolyn in colon cancer: in vitro and in vivo analysis.
    Aliabadi A; Haghshenas MR; Kiani R; Panjehshahin MR; Erfani N
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):207. PubMed ID: 38647571
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Implementation and Evaluation of a Large Community-Based colorectal cancer Screening Program.
    Shokar NK; Calderón-Mora J; Salaiz R; Casner N; Zuckerman MJ; Byrd TL; Shokar GS; Dwivedi A
    J Public Health Manag Pract; 2024 May-Jun 01; 30(3):E143-E153. PubMed ID: 38603761
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence?
    Stucchi E; Bartolini M; Airoldi M; Fazio R; Daprà V; Mondello G; Prete MG; Puccini A; Santoro A
    Expert Opin Pharmacother; 2024 Mar; 25(4):371-382. PubMed ID: 38568032
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. lncRNA CCAT2 Protects Against Cardiomyocyte Injury After Myocardial Ischemia/Reperfusion by Regulating BMI1 Expression.
    Zhang M; Xu B; Li W; Yu B; Peng H; Gui F; Ai F; Chen Z
    Int Heart J; 2024; 65(2):279-291. PubMed ID: 38556336
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Urocortin-1 promotes colorectal cancer cell migration and proliferation and inhibits apoptosis via inhibition of the p53 signaling pathway.
    Guo X; Li Y; Chen X; Sun B; Guo X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):163. PubMed ID: 38546882
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
    He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
    J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [A Case of Desmoid-Type Fibromatosis of the Mesentery of Small Intestine].
    Ogura T; Kunisaki C; Sato S; Sato T; Endo I
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):334-335. PubMed ID: 38494823
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic colorectal cancer: WJOG 11018G.
    Matsumoto T; Yamamoto Y; Kotaka M; Masuishi T; Tsuji Y; Shoji H; Hirata K; Tsuduki T; Makiyama A; Izawa N; Takahashi N; Tsuda M; Yasui H; Ohta T; Kito Y; Otsu S; Hironaka S; Yamazaki K; Boku N; Hyodo I; Yoshimura K; Muro K
    Target Oncol; 2024 Mar; 19(2):181-190. PubMed ID: 38427280
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. "A Huge Gap": Health Care Provider Perspectives on cancer Screening for Aboriginal and Torres Strait Islander People in the Northern Territory.
    Taylor EV; Dugdale S; Connors CM; Garvey G; Thompson SC
    Int J Environ Res Public Health; 2024 Jan; 21(2):. PubMed ID: 38397632
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. HSK3486 Inhibits colorectal cancer Growth by Promoting Oxidative Stress and ATPase Inhibitory Factor 1 Activation.
    Nan K; Zhong Z; Yue Y; Zhou W; Sun X; Shen Y; Qu M; Chen Z; Gu J; Sun C; Sun X; Lu L; Zhang J; Miao C; Sun M
    Dig Dis Sci; 2024 Apr; 69(4):1214-1227. PubMed ID: 38376789
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
    Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI
    Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The epigenetic downregulation of LncGHRLOS mediated by RNA m6A methylase ZCCHC4 promotes colorectal cancer tumorigenesis.
    Chen K; Zhang J; Meng L; Kong L; Lu M; Wang Z; Wang W
    J Exp Clin Cancer Res; 2024 Feb; 43(1):44. PubMed ID: 38326863
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Study on Thymoquinone: Antioxidant Capacity and Anticancer Activities in LoVo colorectal cancer Cells.
    Bozali K; Metin Guler E; Kocyigit A
    Chem Biodivers; 2024 Feb; 21(2):e202301886. PubMed ID: 38308180
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Decisions and prompts to screen for cervical, bowel, and breast cancer.
    Anderson LE; Collins KE; Myers L; Ireland MJ; Omar M; Drummond A; Goodwin BC
    Patient Educ Couns; 2024 May; 122():108174. PubMed ID: 38295667
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Huaier Regulates Oxaliplatin Resistance in colorectal cancer by Regulating Autophagy and Inhibiting the Wnt/β-catenin Signalling Pathway.
    Feng Q; Huo M; Yan X; Wen L; Zheng J
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):15. PubMed ID: 38287798
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 85.